Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Long-Term Investments: 2022-2024

Historic Long-Term Investments for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $2.5 million.

  • Orchestra BioMed Holdings' Long-Term Investments changed negligibly% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.5 million for FY2024, which is 0.20% up from last year.
  • Orchestra BioMed Holdings' Long-Term Investments amounted to $2.5 million in FY2024, which was up 0.20% from $2.5 million recorded in FY2023.
  • Orchestra BioMed Holdings' Long-Term Investments' 5-year high stood at $2.5 million during FY2024, with a 5-year trough of $2.5 million in FY2022.
  • Moreover, its 3-year median value for Long-Term Investments was $2.5 million (2023), whereas its average is $2.5 million.
  • Data for Orchestra BioMed Holdings' Long-Term Investments shows a peak YoY climbed of 0.20% (in 2024) over the last 5 years.
  • Orchestra BioMed Holdings' Long-Term Investments (Yearly) stood at $2.5 million in 2022, then remained steady at $2.5 million in 2023, then increased by 0.20% to $2.5 million in 2024.